Awen Oncology is a new therapeutic and allied biomarker development company in the oncology sector. We have identified a series of novel therapeutic cancer-specific targets and associated small molecule inhibitors that serve as precursors to clinically relevant therapeutics for the treatment of a wide range of cancer types.